This Webinar Has Now Concluded

ADCs: New Ways to Achieve Precision Conjugation and Scalable Purification

 

 

October 7th: 6pm CEST | 5pm BST | 12pm EDT | 9am PDT

Although highly successful, the complexities involved in controlling conjugation reactions and purifying the final drug mean it remains especially challenging to manufacture and develop processes for ADC compounds. In this webinar, sponsored by Cytiva, our main speakers and panelists will highlight chemical methods to precisely control stoichiometry and mixing during conjugation, dramatically reducing HMW impurities at the source, simplifying your entire workflow. We will also learn more about scalable purification processes for ADCs, tackling key challenges like free drug removal through integrating protein A capture, cation exchange chromatography, and TFF to boost the robustness of your ADC development and manufacturing processes. 

This webinar has now concluded

Key Highlights:

  • Presentation of a flow chemistry method to control conjugation stoichiometry and limit HMW impurities
  • Insight into an integrated large-scale purification process for antibodies and ADCs, including strategies to overcome the critical challenge of free drug removal.
  • Expert panel discussion discussing most pressing issues in ADC process development & manufacturing today

Why Attend:

  • Get practical tips to gain precise control over the conjugation reaction, reducing impurities at the source and significantly simplifying your downstream process.
  • Learn about scalable purification strategies using chromatography and TFF, ultimately saving you time and resources in developing your processes.
  • Opportunity to put your questions to our panel of experts and speakers

Join us for an informative session that will help understand how to achieve superior conjugate quality, reduce purification burdens, and accelerate your ability to develop better manufacturing processes.

Main Speakers

Christopher Spedaliere

Senior Scientist, Ex-Merck

Cecille Oblette

Scientist, ADC Therapeutics

Beccie Martin

Conjugation Scientist II, ADC Therapeutics

Fireside Chat Panellists

Ernest Kovacs

Senior Director, ADC Conjugation Development, Immunome 

Sara Wichner

Bioconjugation Chemist, Genentech

Fara Lyu

Senior Scientist, AbbVie

Learn More About Consulting

What is Beacon Consulting?
  • We are specialist life sciences market research and consultants, delivering tailored insights across the full drug development and commercialisation lifecycle.
  • Combines scientific expertise, expert networks, and proprietary Beacon data to transform complex data into clear, strategic decisions.
  • Provides fully customised research, spanning qualitative interviews, quantitative analysis, and desk research, aligned to your specific business objectives.
  • Helps biopharma teams reduce risk, identify opportunities, and accelerate decision-making with actionable, decision-ready insights.
Learn More About Beacon Consulting

What is Beacon?

Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.

Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.

We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!

Request Demonstration

Menu
Search Icon
Close Icon
Search